Shanti Educat. (539921)

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 14.11% suggests decent operating capital efficiency despite weak equity returns.
• Latest quarterly net loss of only ₹1 Cr on ₹6 Cr revenue keeps the reported loss small in absolute terms.
• Price is near the lower end of the 52-week range, indicating some bad news may already be reflected.
• Book value of ₹4.78 provides a tangible, though modest, net worth base.

Concerns

• Sales growth collapsed by 71.63% and profit growth turned sharply negative at -131.28%.
• P/E of 721x and P/B of 19.62x are extremely expensive against an ROE of just 5.52%.
• Piotroski F-Score of 3/9 and FairStock Score of 0/100 flag poor fundamentals and high risk.
• No dividend and no promoter holding disclosure reduce transparency and income support.

AI Analysis

Let me start with the obvious: I cannot value a business if its earnings have collapsed. Shanti Educat trades at ₹93.78 with a market cap of ₹1,547 Cr, but that price is built on a P/E of 721x. That is not a sign of quality; it is simply arithmetic when profit has nearly vanished. Sales are down 71.63% and profit growth is minus 131.28%. In the latest quarter, revenue was just ₹6 Cr and the company lost ₹1 Cr. The book value is ₹4.78, so at ₹93.78 you are paying nearly 20 times net worth for a business earning only 5.52% on equity. A 14.11% ROCE is the only bright spot, but it does not rescue the valuation when sales are shrinking. The Piotroski score of 3 out of 9 reinforces my caution: financial health is weak. There is no dividend to reward the patient holder. The share price is near its 52-week low of ₹96.05, down from ₹218.45, and the market is already repricing something. As Graham said, the stock market is a voting machine in the short run and a weighing machine in the long run. Right now, the weighing machine shows uncertainty, not value. I would need clear evidence of stabilised revenue, improved margins, and a credible explanation for the collapse before I could consider this. Paying ₹1,547 Cr for a company with roughly ₹79 Cr of equity and quarterly sales of ₹6 Cr is not investing; it is speculation. In Buffett's terms, it is a wonderful business only if the numbers start saying so. They do not. I would keep it on the watch list, not in my portfolio.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer